+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 10Years - 18Years
All Genders
ID06365892

Open-label Placebo to Manage Pain in Children Aged 10 to 18 Undergoing Surgery for Idiopathic Scoliosis

Led by University of California, San Francisco · Updated on 2026-03-13

64

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of adding an open-label placebo COLP to the usual postoperative treatment for adolescents aged 10 to 18 undergoing surgery for idiopathic scoliosis. This randomized controlled trial will involve 64 patients divided into two groups to compare opioid consumption and other clinical outcomes over 6 weeks following surgery. The study also examines associations between pain perception, anxiety, depression, and response to the treatments. Participants will be randomly assigned to either receive open-label placebo tablets along with standard treatment or standard treatment alone. The placebo is a 330mg tablet taken with each opioid dose and three additional times daily, starting the day after surgery. Standard treatment includes opioid analgesics 5mg Oxycodone tablets and Tylenol, with specific restrictions on other medications. The trial will last 6 weeks with detailed monitoring. Throughout the study, clinical data will be collected at regular clinic visits, including patient surveys using PROMIS scales to assess mobility, anxiety, and depressive symptoms. Researchers will track opioid use, physical therapy independence, hospital stay length, return to school time, and side effects such as urinary retention, constipation, and oxygen needs. The total participation period covers from hospital admission to 6 weeks post-surgery, with close monitoring of recovery and medication use.

CONDITIONS

Brief Title

Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis

Research Team

M

Mohammad Diab, MD

T

Tripta Rughwani

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here